| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.008 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.008 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |